AMERIGEN PHARMACEUTICALS Trademark

Trademark Overview

On Tuesday, November 15, 2011, a trademark application was filed for AMERIGEN PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the AMERIGEN PHARMACEUTICALS trademark a serial number of 85472700. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 1, 2016. This trademark is owned by Amerigen Pharmaceuticals, Ltd.. The AMERIGEN PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of hypertension, depression, cardiovascular disease, allergies, neurological disorders, gastro-intestinal disease, urinary incontinence, Parkinson's disease, Alzheimer's disease, oncology, diabetes and metabolic disorders, dermatological disorders, bipolar disorder and schizophrenia, vitamin D deficiency, bleeding disorders, BPH or benign prostatic hyperplasia, erectile dysfunction and pain, women's health issues relating to birth control, menstruation, menopause, breast health and disorders, sexual health and disorders, female reproductive health and disorders, pregnancy and autoimmune diseases
amerigen pharmaceuticals

General Information

Serial Number85472700
Word MarkAMERIGEN PHARMACEUTICALS
Filing DateTuesday, November 15, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 1, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 30, 2012

Trademark Statements

Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesPharmaceutical preparations for the prevention and treatment of hypertension, depression, cardiovascular disease, allergies, neurological disorders, gastro-intestinal disease, urinary incontinence, Parkinson's disease, Alzheimer's disease, oncology, diabetes and metabolic disorders, dermatological disorders, bipolar disorder and schizophrenia, vitamin D deficiency, bleeding disorders, BPH or benign prostatic hyperplasia, erectile dysfunction and pain, women's health issues relating to birth control, menstruation, menopause, breast health and disorders, sexual health and disorders, female reproductive health and disorders, pregnancy and autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 18, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmerigen Pharmaceuticals, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressKY1-1111
KY
Party NameAmerigen Pharmaceuticals, Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKY1-1111
KY

Trademark Events

Event DateEvent Description
Monday, February 1, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 1, 2016ABANDONMENT - NO USE STATEMENT FILED
Friday, July 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 2, 2015EXTENSION 5 GRANTED
Thursday, June 11, 2015EXTENSION 5 FILED
Thursday, June 11, 2015TEAS EXTENSION RECEIVED
Saturday, January 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 2, 2015EXTENSION 4 GRANTED
Monday, December 22, 2014EXTENSION 4 FILED
Monday, December 22, 2014TEAS EXTENSION RECEIVED
Tuesday, July 1, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 30, 2014EXTENSION 3 GRANTED
Friday, June 20, 2014EXTENSION 3 FILED
Friday, June 20, 2014TEAS EXTENSION RECEIVED
Wednesday, January 22, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 21, 2014EXTENSION 2 GRANTED
Monday, December 23, 2013EXTENSION 2 FILED
Monday, December 23, 2013TEAS EXTENSION RECEIVED
Thursday, June 13, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 12, 2013EXTENSION 1 GRANTED
Monday, May 13, 2013EXTENSION 1 FILED
Saturday, June 8, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 13, 2013TEAS EXTENSION RECEIVED
Tuesday, December 25, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 30, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 30, 2012PUBLISHED FOR OPPOSITION
Wednesday, October 10, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 21, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 17, 2012ASSIGNED TO LIE
Friday, September 7, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 6, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 5, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 5, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 5, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 5, 2012NON-FINAL ACTION E-MAILED
Monday, March 5, 2012NON-FINAL ACTION WRITTEN
Friday, March 2, 2012ASSIGNED TO EXAMINER
Friday, November 18, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 18, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceuticals amerigen disorders disease health pain women issues dysfunction benign bleeding prostatic